A Medical Device Daily

dbMotion (Pittsburgh), a provider of health interoperability and intelligence solutions, said it has been chosen by UMass Memorial Health Care (Worcester, Massachusetts) to deliver its interoperability and intelligence system to create a single electronic, interoperable patient record across numerous information technology environments and care areas.

UMass Memorial Health Care is the largest integrated healthcare system in Central and Western Massachusetts, with more than 10,000 employees, including 1,500 physicians and 2,500 nurses.

The clinical partner of the University of Massachusetts Medical School, its network includes UMass Memorial Medical Center, with three campuses, and four community hospitals – Clinton Hospital, HealthAlliance Hospital, Marlborough Hospital and Wing Memorial Hospital.

The network also includes community physician-based practices, home health, hospice, rehabilitation and behavioral health services.

UMass Memorial provides the region with specialists in a range of clinical areas, including cardiology, orthopedics, cancer, emergency medicine, surgery, women's health and children's medical services.

The dbMotion Solution is a service-oriented architecture platform that enables healthcare organizations and exchanges to integrate patient information. The company said the solution can extend the life of working clinical solutions that do not fit into a homogenous IT architecture and can provide a platform for development to solve new clinical problems.

"UMass Memorial's vision of excellence in healthcare provision supported through innovative technology made dbMotion a natural choice as a strategic partner," said George Brenckle, senior vice president and chief information officer for UMass Memorial Health Care. "Their vision for integrated care and interoperable, unified medical records is tightly aligned with ours."

He added, "dbMotion's advanced, healthcare-focused platform, will allow us to deliver critical medical information to the point of care regardless of where the care is delivered."

The first phase of the project will be deployed with medical domains including patient medications, allergies, laboratory, radiology and extensive clinical documentation.

Peter McClennen, president of North America for dbMotion, said, "We welcome the opportunity to deliver our technology and join with UMass Memorial to advance the state of integrated care in Massachusetts. We believe that by providing access to integrated patient information through the solution's ability to connect care settings we can help to bridge gaps that often exist between acute and community care while providing a compelling return on investment."

In other agreements/contracts news:

• Affiliated Computer Services (ACS; Dallas) reported a $21 million, 18-month contract renewal with the Hawaii Department of Human Services to provide fiscal agent services, as well as services related to processing pharmacy and non-pharmacy claims for Hawaii Medical Assistance Programs.

As part of the contract, ACS will deploy its electronic health record tool, DirectAccessEHR, to aid Hawaiian healthcare providers and payers improve the delivery of quality healthcare, increase efficiency, and support safety.

"This renewal extends ACS' longstanding relationship with the State of Hawaii, and demonstrates how prior experience and the ability to introduce innovative services can deliver tremendous benefits for the citizens of Hawaii," said Christopher Deelsnyder, senior vice president and managing director for ACS' Government Healthcare Solutions unit.

ACS has provided fiscal agent services for the state's Medicaid program since 2002, and delivered pharmacy services since 2001. This recent contract is the result of a re-bid for Hawaii's Medicaid Management Information System and Pharmacy Benefit Management and for the first time, consolidates the two programs into a single contract. The contract includes two, one-year options.

• Response Genetics (Los Angeles), a company focused on the development of molecular diagnostic tests for cancer, reported signing a nonexclusive license with Roche Diagnostics (Indianapolis) for the use of Response Genetics' polymerase chain reaction (PCR) analysis to assess human epidermal growth factor type 2 (HER2) gene expression.

The company noted that the accurate measurement of HER2 gene expression can assist physicians with treatment decisions for patients with cancers in tissues such as breast.

"We are extremely pleased to be working with Roche to help make personalized medicine a reality for cancer patients," said Kathleen Danenberg, Response Genetics' president/CEO. "This agreement strengthens our long relationship with Roche and fulfills a promise we made during our initial public offering to license our intellectual property while protecting our intellectual capital freedom."

• Aspyra (Calabasas, California) said that it has contracted with Glendale MRI Institute (Glendale, California), a multi-modality imaging center, to upgrade the center's existing Aspyra PACS to the most current release, version 6.4, as well as implement the company's RIS solution, thereby resulting in the use of Aspyra's integrated RIS/PACS solution by the center.

Glendale MRI has been an Aspyra PACS customer since 2003. Performing more than 10,000 studies annually, the center offers various outpatient imaging services, including MRI, PET/CT, CT, Bone Densitometry and Ultrasound.